Intellia Therapeutics, Inc. 8-K Analysis & Summary – 2/21/2025

⚠️This is not investment advice.

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️

Filing date:

02/21/2025


TLDR:

Intellia Therapeutics, Inc. entered into a lease agreement for new office and laboratory space and amended a previous lease agreement.

ELI5:

Intellia Therapeutics is expanding its office and lab space in Cambridge and reducing its space in Waltham. They’re signing a new lease for a bigger space and modifying an existing lease to reduce costs.


Accession #:

0001193125-25-031989

Published on

Analyst Summary

  • Intellia Therapeutics entered into a Lease Agreement for space at 400 Technology Square, Cambridge, MA.
  • The company will initially lease approximately 101,000 square feet, with an option to expand by approximately 46,000 square feet.
  • The lease is expected to commence on July 1, 2025, with rent starting approximately 14 months later.
  • The initial term of the lease is twelve years and three months, with an option to extend for an additional five years.
  • The base rent is expected to be $108.00 per square foot per year, subject to annual increases of 3%.
  • The Tech Square Landlord will contribute up to $41.5 million toward construction and tenant improvements.
  • The company entered into a Second Amendment to Lease for space at 840 Winter Street, Waltham, MA, which will terminate on or before June 30, 2028.
  • The Company will pay lease modification payments totaling $78 million in three installments.
  • The Company will not pay any base rent, operating expenses or other costs pursuant to the Winter Street Lease after January 2025.

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️